Efficacy and safety of spesolimab for generalized pustular psoriasis treatment according to flare trigger

被引：0
|
作者：
de la Cruz, Claudia [1 ]
Morita, Akimichi [2 ]
Elewski, Boni [3 ]
Ghoreschi, Kamran [4 ,5 ,6 ,7 ]
Ye, Binqi [8 ]
Marshall, S. Renee [9 ]
Thoma, Christian [10 ]
Choon, Siew Eng [11 ]
机构：
[1] Clin Dermacross, Santiago, Chile
[2] Nagoya City Univ, Dept Geriatr & Environm Dermatol, Grad Sch Med Sci, Nagoya, Japan
[3] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
[4] Charit Univ Med, Dept Dermatol Venereol & Allergol, Berlin, Germany
[5] Freie Univ, Berlin, Germany
[6] Humboldt Univ, Berlin, Germany
[7] Berlin Inst Hlth, Berlin, Germany
[8] Boehringer Ingelheim China Investment Co Ltd, Shanghai, Peoples R China
[9] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[10] Boehringer Ingelheim Int GmbH, Biberach, Germany
[11] Monash Univ Malaysia, Dept Dermatol, Hosp Sultanah Aminah, Clin Sch Johor Bahru, Subang Jaya, Malaysia
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
43751
引用
收藏
页码：AB42 / AB42
页数：1
相关论文
共 50 条
  • [21] Spesolimab in the Management of Generalized Pustular Psoriasis With Concurrent Bullous Pemphigoid and Psoriasis
    Teshima, Romane
    Saito -Sasaki, Natsuko
    Hitaka, Taiyo
    Sawada, Yu
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [22] Efficacy of spesolimab in patients with generalized pustular psoriasis (GPP) flares with and without systemic inflammation
    Holsapple, J.
    Schnitzler, L.
    Rusch, L.
    Baldeweg, T. H.
    Neubert, E.
    Kruss, S.
    Erpenbeck, L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (12) : S245 - S245
  • [23] Generalized pustular psoriasis successfully treated with spesolimab: A case report
    Brigenti, Noemi
    Gisondi, Paolo
    Bellinato, Francesco
    Girolomoni, Giampiero
    SAGE OPEN MEDICAL CASE REPORTS, 2024, 12
  • [24] Efficacy and safety of spesolimab in Asian patients with a generalized pustular psoriasis flare: Results from the randomized, double-blind, placebo-controlled Effisayil™ 1 study
    Morita, Akimichi
    Tsai, Tsen-Fang
    Yee, Evelyn Yap Wen
    Okubo, Yukari
    Imafuku, Shinichi
    Zheng, Min
    Li, Ling
    Quaresma, Manuel
    Thoma, Christian
    Choon, Siew Eng
    JOURNAL OF DERMATOLOGY, 2023, 50 (02): : 183 - 194
  • [25] Generalized pustular psoriasis: consequences of tedious procurement of spesolimab in Germany
    Sollfrank, Lukas
    Sticherling, Michael
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [26] Spesolimab, an interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis
    Burden, A. David
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (05) : 473 - 481
  • [27] Effectiveness and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Single- centre Retrospective Study
    Okada, Yoshiki
    Kamata, Masahiro
    Hayashi, Kotaro
    Sugiura, Kazumitsu
    Tada, Yayoi
    ACTA DERMATO-VENEREOLOGICA, 2025, 105
  • [28] Crusted Scabies in a Patient being Treated with Spesolimab for Generalized Pustular Psoriasis
    Schratter, Hanna
    Graier, Thomas
    Legat, Franz
    Hofmann-wellenhof, Rainer
    Wolf, Peter
    ACTA DERMATO-VENEREOLOGICA, 2025, 105
  • [29] Effisayil ON, an open-label, long-term extension study of spesolimab treatment in patients with generalized pustular psoriasis: interim results for flare treatment
    Navarini, Alexander A.
    Bachelez, Herve
    Choon, Siew Eng
    Jaya, Subang
    Burden, A. David
    Zheng, Min
    Morita, Akimichi
    Tanaka, Yuko
    Ye, Binqi
    Thoma, Christian
    Lebwohl, Mark G.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB44 - AB44
  • [30] Successful treatment of acrodermatitis continua of Hallopeau coexisting with generalized pustular psoriasis with spesolimab: a case report
    Wen, Pengfei
    Liu, Chuan
    Wang, Tingting
    Jiang, Xian
    Wang, Ping
    Wang, Sheng
    FRONTIERS IN IMMUNOLOGY, 2024, 15
12345